出 典 Berger PB, et al:CHARISMA Investigators: Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease:results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance(CHARISMA)trial. Circulation 121:2575-2583, 2010 ※図表に関しましては、割愛させていただいております。